InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（5 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
5
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Sodhi Rajwant, 董事长兼首席执行官. Officer active across 3 companies, notably RESMED INC. Aggregated, 13 filings have been recorded. Split: 0 buy · 5 sells. Total volume traded: €1.5m. Activity tracked since 3 May 2021. The latest transaction was filed on 22 May 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Sodhi Rajwant
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
4,387 股@ US$20.6425.1% 占其流量Common StockSEC:0001438133-25-000109:0
4,434 股@ US$51.7366.4% 占其流量Common StockSEC:0001438133-24-000122:0
1,070 股@ US$27.668.5% 占其流量Common StockSEC:0001438133-24-000002:0
2,757 股0Common StockSEC:0001438133-23-000110:0
1,069 股0Common StockSEC:0001438133-23-000002:0
735 股0Common StockSEC:0001438133-22-000101:0
1,069 股0Common StockSEC:0001438133-22-000004:0
1,500 股@ US$288.4124.2% 占其流量ResMed Common StockSEC:0001127602-21-024859:0
4,066 股0ResMed Common StockSEC:0001127602-21-024092:0
1,500 股@ US$269.0022.5% 占其流量ResMed Common StockSEC:0001127602-21-022839:0
1,500 股@ US$245.7220.6% 占其流量ResMed Common StockSEC:0001127602-21-021160:0
1,500 股@ US$207.1316.9% 占其流量ResMed Common StockSEC:0001127602-21-018662:0
1,500 股@ US$190.5015.7% 占其流量ResMed Common StockSEC:0001127602-21-015115:0
13 条申报中的 13 条
About Sodhi Rajwant
Sodhi Rajwant is President, SaaS Business. He has filed 20 filings in total, and in the recent filings held, the transactions are sales, for a total amount of EUR 3015011 between 2021-05-04 and 2025-05-23. He is also listed at RESMED INC, and at Tandem Diabetes Care INC, as Director, as well as at TANDEM DIABETES CARE INC, as Director.
